{
    "@context": {
        "@vocab": "https://openminds.ebrains.eu/vocab/"
    },
    "@id": "https://openminds.ebrains.eu/instances/parcellationEntityVersion/AMBA_CCFv3_2015_dopaminergicA13Group",
    "@type": "https://openminds.ebrains.eu/sands/ParcellationEntityVersion",
    "hasAnnotation": [
		{
			"@type": "https://openminds.ebrains.eu/sands/AtlasAnnotation",
			"bestViewPoint": null,
			"criteria": null,
			"criteriaQualityType": null,
			"displayColor": "#F2483B",
			"inspiredBy": null,
			"internalIdentifier": "796",
			"laterality": [
				{
					"@id": "https://openminds.ebrains.eu/instances/laterality/left"
				},
				{
					"@id": "https://openminds.ebrains.eu/instances/laterality/right"
				}
			],
			"visualizedIn": null
		}
	],
    "hasParent": null,
    "lookupLabel": "AMBA_CCFv3_2015_dopaminergicA13Group",
    "name": "dopaminergic A13 group",
    "ontologyIdentifier": null,
    "relationAssessment": null,
    "versionIdentifier": "CCFv3 2015",
    "versionInnovation": null
}
